1 – 20 of 60
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
RNA sequencing unravels novel L cell constituents and mechanisms of GLP-1 secretion in human gastric bypass-operated intestine
(
- Contribution to journal › Article
-
Mark
Lipid exchange of apolipoprotein A-I amyloidogenic variants in reconstituted high-density lipoprotein with artificial membranes
(
- Contribution to journal › Article
- 2023
-
Mark
Type 2 diabetes candidate genes, including PAX5, cause impaired insulin secretion in human pancreatic islets
(
- Contribution to journal › Article
-
Mark
Genetic evidence implicating natriuretic peptide receptor-3 in cardiovascular disease risk : a Mendelian randomization study
(
- Contribution to journal › Article
-
Mark
The Apparent Organ-Specificity of Amyloidogenic ApoA-I Variants Is Linked to Tissue-Specific Extracellular Matrix Components
(
- Contribution to journal › Article
- 2022
-
Mark
Secretory granule exocytosis and its amplification by cAMP in pancreatic β-cells
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol efflux
(
- Contribution to journal › Article
- 2020
-
Mark
Apolipoprotein A-I primes beta cells to increase glucose stimulated insulin secretion
(
- Contribution to journal › Article
-
Mark
A short peptide of the C-terminal class Y helices of apolipoprotein A-I has preserved functions in cholesterol efflux and in vivo metabolic control
(
- Contribution to journal › Article
-
Mark
ApoA-1 improves glucose tolerance by increasing glucose uptake into heart and skeletal muscle independently of AMPKα2
(
- Contribution to journal › Article
- 2019
-
Mark
Anti-ApoA-I IgG antibodies are not associated with carotid artery disease progression and first-time cardiovascular events in middle-aged individuals
(
- Contribution to journal › Article
-
Mark
Novel ABCA1 peptide agonists with antidiabetic action
(
- Contribution to journal › Article
-
Mark
ApoAI-derived peptide increases glucose tolerance and prevents formation of atherosclerosis in mice
(
- Contribution to journal › Article
-
Mark
Loss of ZnT8 function protects against diabetes by enhanced insulin secretion
(
- Contribution to journal › Article
- 2018
-
Mark
High-efficient bacterial production of human ApoA-I amyloidogenic variants
(
- Contribution to journal › Article
-
Mark
Site-specific glycations of apolipoprotein A-I lead to differentiated functional effects on lipid-binding and on glucose metabolism
(
- Contribution to journal › Article
- 2017
-
Mark
Apolipoprotein A-I attenuates LL-37-induced endothelial cell cytotoxicity
(
- Contribution to journal › Article
-
Mark
Structural determinants in ApoA-I amyloidogenic variants explain improved cholesterol metabolism despite low HDL levels
(
- Contribution to journal › Article
-
Mark
Plasma stem cell factor levels are associated with risk of cardiovascular disease and death
(
- Contribution to journal › Article
-
Mark
Synchrotron radiation circular dichroism spectroscopy reveals structural divergences in HDL-bound apoA-I variants
(
- Contribution to journal › Article